Halo Labs’ Post

#Recombinant C Factor Endotoxin Detection Kit: 🚀 Easy Operation: One-step detection, endpoint fluorescence determination, detection time only 90 minutes. 🚀Excellent Performance: High sensitivity (0.005EU/mL~5EU/mL), good batch-to-batch and intra-batch consistency, and sample recovery rate meets standards. 🚀Exclusive Specificity: No G factor bypass interference, suitable for endotoxin detection in samples with β-glucan interference, avoiding false positives. 🚀Long Stability: The lyophilized standard can be stored at 4°C for up to 60 days after reconstitution, and the kit can be stably stored for 1 year. 🚀Wide Applicability: Suitable for different types of sample detection, sample measurements can correspond to LAL reagents, and applicable to multiple microplate readers. For more details please feel free to contact or visit our website. https://hzymesbiotech.com/ Our mRNA CRO Services: www.hzymescro.com/en #Biopharma #Biotech #LabLife #ResearchTools #LabTech #RecombinantCFactor #Endotoxin #EndotoxinDetection

[The world of mRNA] Two of the most significant obstacles in mRNA therapeutics development are mRNA’s intrinsic instability and its immunogenicity. 🔎In order to address these challenges, several different approaches can be used, including optimization of 3 poly(A) tail length. 🚫However, long (>120 nt) stretches of thymidines in DNA sequence can lead to cloning difficulties, plasmid instability during culture and formation of multimeric plasmid structures. Learn about our efforts to improve the understanding of in vitro polyadenylation (PA) reaction. Read on: https://lnkd.in/dBdXdx_y #mRNA #therapeutics #purification #chromatography #biotechnology

If you're not attending the Peptide Summit you're going to miss out on Jason Deng's talk. I got a sneak peak of his presentation last night and I must say it is definitely interesting and innovative. If you'd like to learn more about our peptide-DEL capabilities or if you want to connect with Jason let me know!

Thoughts on this? >> CRL delays Abeona's dystrophic epidermic bullosa bid - BioWorld Online >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #competitivemarketing #pharma #healthcare

CRISPR-Cas9 : A Revolutionary Gene Editing Tool. * It is a gene editing system derived from bacteria. 🦠 * It allows for precise cutting of DNA at specific locations. ✂️ * It is composed of a guide RNA and a Cas9 enzyme. * The guide RNA directs the Cas9 enzyme to a specific DNA sequence. 🧬 * Cas9 cuts both strands of DNA at that location. * The cell repairs the break, allowing for the insertion, deletion, or modification of genes. #CrisprCas9 #gene_editing #biotechnology

Thoughts on this? >> Patient dies in Pfizer’s Phase 2 Duchenne muscular dystrophy trial >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #productmarketing #pharma #biotech #pharmaceutical

This #biopharmaanimation showcases a promising therapeutic technology for treating and preventing COVID-19 using Elovonoids and Resolvins. Our client is exploring innovative therapeutic approaches to combat COVID-19. They are focusing on blocking SARS-CoV-2 entry into cells and reducing disease severity using elovonoids and novel resolvins, which are lipid mediators derived from polyunsaturated fatty acids. Elovonoids, a newly discovered class of bioactive derivatives, protect cells by enhancing the expression of pro-survival and pro-homeostatic proteins while reducing apoptosis-promoting proteins. In vitro studies conducted by our client have demonstrated that these lipid mediators can lead to the synthesis of elovonoids in lung cells, downregulate the expression of ACE2 (the SARS-CoV-2 receptor), inhibit viral cell entry, and suppress inflammatory responses, thus mitigating hyperinflammation and cytokine storms. Learn more about our work 👉 biotech-animated.com #medicalanimation #pharma #biotechnology #molecularbiology #resolvins

🚀 Excited to connect with you at TIDES Europe in Hamburg! Visit us at booth #316! Our peptide experts, Cátia Teixeira and Luísa Aguiar, are ready to show how our PurePep solutions can power up your peptide projects. 💡 Peptide therapeutics is advancing fast, with two key trends shaping the field: ⭐ Innovative Screening Platforms: Target-based drug development is being transformed by advanced chemical and display screening platforms, enriching the preclinical pipeline. ⭐ GLP-1 Analogs Success: The rise of GLP-1 analogs in weight loss and obesity treatments is sparking new demand in peptide synthesis—resulting in both opportunity and capacity challenges. 🌱 Don’t miss Luísa's poster presentation, "Greener Synthesis and Purification Solutions in the New Era of Peptide Therapeutics." Dive into sustainable peptide development and explore the trends defining the future. We’re here to help you navigate this evolution—see you at booth #316! #PurePep #ForPeptideScientists #Synthesis #Purification

Thoughts on this? >> CRL delays Abeona's dystrophic epidermic bullosa bid - BioWorld Online >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #healthcare #pharma #pharmaceutical #competitivemarketing